Mechanisms for regulation of RAS palmitoylation and plasma membrane trafficking in hematopoietic malignancies

Palmitoylation is a critical posttranslational modification that enables the cellular membrane localization and subsequent activation of RAS proteins, including HRAS, KRAS, and NRAS. However, the molecular mechanism that regulates RAS palmitoylation in malignant diseases remains unclear. In this iss...

Full description

Bibliographic Details
Main Authors: Fang Yu, Zhijian Qian
Format: Article
Language:English
Published: American Society for Clinical Investigation 2023-06-01
Series:The Journal of Clinical Investigation
Online Access:https://doi.org/10.1172/JCI171104
_version_ 1797634405569658880
author Fang Yu
Zhijian Qian
author_facet Fang Yu
Zhijian Qian
author_sort Fang Yu
collection DOAJ
description Palmitoylation is a critical posttranslational modification that enables the cellular membrane localization and subsequent activation of RAS proteins, including HRAS, KRAS, and NRAS. However, the molecular mechanism that regulates RAS palmitoylation in malignant diseases remains unclear. In this issue of the JCI, Ren, Xing, and authors shed light on this topic and revealed how upregulation of RAB27B, as a consequence of CBL loss and Janus kinase 2 (JAK2) activation, contributes to leukemogenesis. The authors found that RAB27B mediated NRAS palmitoylation and plasma membrane localization by recruiting ZDHHC9. The findings suggest that targeting RAB27B could provide a promising therapeutic strategy for NRAS-driven cancers.
first_indexed 2024-03-11T12:08:22Z
format Article
id doaj.art-006ad66114364133b740fbdc988154ec
institution Directory Open Access Journal
issn 1558-8238
language English
last_indexed 2024-03-11T12:08:22Z
publishDate 2023-06-01
publisher American Society for Clinical Investigation
record_format Article
series The Journal of Clinical Investigation
spelling doaj.art-006ad66114364133b740fbdc988154ec2023-11-07T16:20:29ZengAmerican Society for Clinical InvestigationThe Journal of Clinical Investigation1558-82382023-06-0113312Mechanisms for regulation of RAS palmitoylation and plasma membrane trafficking in hematopoietic malignanciesFang YuZhijian QianPalmitoylation is a critical posttranslational modification that enables the cellular membrane localization and subsequent activation of RAS proteins, including HRAS, KRAS, and NRAS. However, the molecular mechanism that regulates RAS palmitoylation in malignant diseases remains unclear. In this issue of the JCI, Ren, Xing, and authors shed light on this topic and revealed how upregulation of RAB27B, as a consequence of CBL loss and Janus kinase 2 (JAK2) activation, contributes to leukemogenesis. The authors found that RAB27B mediated NRAS palmitoylation and plasma membrane localization by recruiting ZDHHC9. The findings suggest that targeting RAB27B could provide a promising therapeutic strategy for NRAS-driven cancers.https://doi.org/10.1172/JCI171104
spellingShingle Fang Yu
Zhijian Qian
Mechanisms for regulation of RAS palmitoylation and plasma membrane trafficking in hematopoietic malignancies
The Journal of Clinical Investigation
title Mechanisms for regulation of RAS palmitoylation and plasma membrane trafficking in hematopoietic malignancies
title_full Mechanisms for regulation of RAS palmitoylation and plasma membrane trafficking in hematopoietic malignancies
title_fullStr Mechanisms for regulation of RAS palmitoylation and plasma membrane trafficking in hematopoietic malignancies
title_full_unstemmed Mechanisms for regulation of RAS palmitoylation and plasma membrane trafficking in hematopoietic malignancies
title_short Mechanisms for regulation of RAS palmitoylation and plasma membrane trafficking in hematopoietic malignancies
title_sort mechanisms for regulation of ras palmitoylation and plasma membrane trafficking in hematopoietic malignancies
url https://doi.org/10.1172/JCI171104
work_keys_str_mv AT fangyu mechanismsforregulationofraspalmitoylationandplasmamembranetraffickinginhematopoieticmalignancies
AT zhijianqian mechanismsforregulationofraspalmitoylationandplasmamembranetraffickinginhematopoieticmalignancies